Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 70

1.

Biology of breast cancer during pregnancy using genomic profiling.

Azim HA Jr, Brohée S, Peccatori FA, Desmedt C, Loi S, Lambrechts D, Dell'Orto P, Majjaj S, Jose V, Rotmensz N, Ignatiadis M, Pruneri G, Piccart M, Viale G, Sotiriou C.

Endocr Relat Cancer. 2014 Aug;21(4):545-54. doi: 10.1530/ERC-14-0111. Epub 2014 May 13.

PMID:
24825746
[PubMed - in process]
2.

Impact of tumor sequencing on the use of anticancer drugs.

Thomas F, Desmedt C, Aftimos P, Awada A.

Curr Opin Oncol. 2014 May;26(3):347-56. doi: 10.1097/CCO.0000000000000078.

PMID:
24709974
[PubMed - in process]
3.

Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial.

Loi S, Michiels S, Salgado R, Sirtaine N, Jose V, Fumagalli D, Kellokumpu-Lehtinen PL, Bono P, Kataja V, Desmedt C, Piccart MJ, Loibl S, Denkert C, Smyth MJ, Joensuu H, Sotiriou C.

Ann Oncol. 2014 Aug;25(8):1544-50. doi: 10.1093/annonc/mdu112. Epub 2014 Mar 7.

PMID:
24608200
[PubMed - in process]
Free Article
4.

TP53 mutation-correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53-mutated breast cancers.

Győrffy B, Bottai G, Lehmann-Che J, Kéri G, Orfi L, Iwamoto T, Desmedt C, Bianchini G, Turner NC, de Thè H, André F, Sotiriou C, Hortobagyi GN, Di Leo A, Pusztai L, Santarpia L.

Mol Oncol. 2014 May;8(3):508-19. doi: 10.1016/j.molonc.2013.12.018. Epub 2014 Jan 5.

PMID:
24462521
[PubMed - in process]
5.

Infrared imaging in breast cancer: automated tissue component recognition and spectral characterization of breast cancer cells as well as the tumor microenvironment.

Benard A, Desmedt C, Smolina M, Szternfeld P, Verdonck M, Rouas G, Kheddoumi N, Rothé F, Larsimont D, Sotiriou C, Goormaghtigh E.

Analyst. 2014 Mar 7;139(5):1044-56. doi: 10.1039/c3an01454a.

PMID:
24418921
[PubMed - in process]
6.

The technologically integrated oncosimulator: combining multiscale cancer modeling with information technology in the in silico oncology context.

Stamatakos G, Dionysiou D, Lunzer A, Belleman R, Kolokotroni E, Georgiadi E, Erdt M, Pukacki J, Rüeping S, Giatili S, d'Onofrio A, Sfakianakis S, Marias K, Desmedt C, Tsiknakis M, Graf N.

IEEE J Biomed Health Inform. 2014 May;18(3):840-54. doi: 10.1109/JBHI.2013.2284276. Epub 2013 Oct 2.

PMID:
24108720
[PubMed - in process]
7.

TOP2A protein by quantitative immunofluorescence as a predictor of response to epirubicin in the neoadjuvant treatment of breast cancer.

Moretti E, Desmedt C, Biagioni C, Regan MM, Oakman C, Larsimont D, Galardi F, Piccart-Gebhart M, Sotiriou C, Rimm DL, Di Leo A.

Future Oncol. 2013 Oct;9(10):1477-87. doi: 10.2217/fon.13.103.

PMID:
24106899
[PubMed - indexed for MEDLINE]
8.

Signatures of mutational processes in human cancer.

Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV, Bignell GR, Bolli N, Borg A, Børresen-Dale AL, Boyault S, Burkhardt B, Butler AP, Caldas C, Davies HR, Desmedt C, Eils R, Eyfjörd JE, Foekens JA, Greaves M, Hosoda F, Hutter B, Ilicic T, Imbeaud S, Imielinski M, Jäger N, Jones DT, Jones D, Knappskog S, Kool M, Lakhani SR, López-Otín C, Martin S, Munshi NC, Nakamura H, Northcott PA, Pajic M, Papaemmanuil E, Paradiso A, Pearson JV, Puente XS, Raine K, Ramakrishna M, Richardson AL, Richter J, Rosenstiel P, Schlesner M, Schumacher TN, Span PN, Teague JW, Totoki Y, Tutt AN, Valdés-Mas R, van Buuren MM, van 't Veer L, Vincent-Salomon A, Waddell N, Yates LR; Australian Pancreatic Cancer Genome Initiative; ICGC Breast Cancer Consortium; ICGC MMML-Seq Consortium; ICGC PedBrain, Zucman-Rossi J, Futreal PA, McDermott U, Lichter P, Meyerson M, Grimmond SM, Siebert R, Campo E, Shibata T, Pfister SM, Campbell PJ, Stratton MR.

Nature. 2013 Aug 22;500(7463):415-21. doi: 10.1038/nature12477. Epub 2013 Aug 14. Erratum in: Nature. 2013 Oct 10;502(7470):258. Imielinsk, Marcin [corrected to Imielinski, Marcin].

PMID:
23945592
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

CD4⁺ follicular helper T cell infiltration predicts breast cancer survival.

Gu-Trantien C, Loi S, Garaud S, Equeter C, Libin M, de Wind A, Ravoet M, Le Buanec H, Sibille C, Manfouo-Foutsop G, Veys I, Haibe-Kains B, Singhal SK, Michiels S, Rothé F, Salgado R, Duvillier H, Ignatiadis M, Desmedt C, Bron D, Larsimont D, Piccart M, Sotiriou C, Willard-Gallo K.

J Clin Invest. 2013 Jul 1;123(7):2873-92. doi: 10.1172/JCI67428. Epub 2013 Jun 17.

PMID:
23778140
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Breast cancer and melanoma cell line identification by FTIR imaging after formalin-fixation and paraffin-embedding.

Verdonck M, Wald N, Janssis J, Yan P, Meyer C, Legat A, Speiser DE, Desmedt C, Larsimont D, Sotiriou C, Goormaghtigh E.

Analyst. 2013 Jul 21;138(14):4083-91. doi: 10.1039/c3an00246b.

PMID:
23689823
[PubMed - indexed for MEDLINE]
11.

Change in the microenvironment of breast cancer studied by FTIR imaging.

Kumar S, Desmedt C, Larsimont D, Sotiriou C, Goormaghtigh E.

Analyst. 2013 Jul 21;138(14):4058-65. doi: 10.1039/c3an00241a.

PMID:
23662300
[PubMed - indexed for MEDLINE]
12.

Association between SPARC mRNA expression, prognosis and response to neoadjuvant chemotherapy in early breast cancer: a pooled in-silico analysis.

Azim HA Jr, Singhal S, Ignatiadis M, Desmedt C, Fumagalli D, Veys I, Larsimont D, Piccart M, Michiels S, Sotiriou C.

PLoS One. 2013 Apr 26;8(4):e62451. doi: 10.1371/journal.pone.0062451. Print 2013. Erratum in: PLoS One. 2013;8(12). doi:10.1371/annotation/3d5a5933-791f-4191-98f5-f559a872e404.

PMID:
23638089
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Genomic grade adds prognostic value in invasive lobular carcinoma.

Metzger-Filho O, Michiels S, Bertucci F, Catteau A, Salgado R, Galant C, Fumagalli D, Singhal SK, Desmedt C, Ignatiadis M, Haussy S, Finetti P, Birnbaum D, Saini KS, Berlière M, Veys I, de Azambuja E, Bozovic I, Peyro-Saint-Paul H, Larsimont D, Piccart M, Sotiriou C.

Ann Oncol. 2013 Feb;24(2):377-84. doi: 10.1093/annonc/mds280. Epub 2012 Oct 1.

PMID:
23028037
[PubMed - indexed for MEDLINE]
Free Article
14.

Next-generation sequencing in breast cancer: first take home messages.

Desmedt C, Voet T, Sotiriou C, Campbell PJ.

Curr Opin Oncol. 2012 Nov;24(6):597-604. doi: 10.1097/CCO.0b013e328359554e. Review.

PMID:
23014189
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Molecular biology in breast cancer: should molecular classifiers be assessed by conventional tools or by gene expression arrays?

Fumagalli D, Andre F, Piccart-Gebhart MJ, Sotiriou C, Desmedt C.

Crit Rev Oncol Hematol. 2012 Dec;84 Suppl 1:e58-69. doi: 10.1016/j.critrevonc.2012.08.003. Epub 2012 Sep 7. Review.

PMID:
22964299
[PubMed - indexed for MEDLINE]
16.

The landscape of cancer genes and mutational processes in breast cancer.

Stephens PJ, Tarpey PS, Davies H, Van Loo P, Greenman C, Wedge DC, Nik-Zainal S, Martin S, Varela I, Bignell GR, Yates LR, Papaemmanuil E, Beare D, Butler A, Cheverton A, Gamble J, Hinton J, Jia M, Jayakumar A, Jones D, Latimer C, Lau KW, McLaren S, McBride DJ, Menzies A, Mudie L, Raine K, Rad R, Chapman MS, Teague J, Easton D, Langerød A; Oslo Breast Cancer Consortium (OSBREAC), Lee MT, Shen CY, Tee BT, Huimin BW, Broeks A, Vargas AC, Turashvili G, Martens J, Fatima A, Miron P, Chin SF, Thomas G, Boyault S, Mariani O, Lakhani SR, van de Vijver M, van 't Veer L, Foekens J, Desmedt C, Sotiriou C, Tutt A, Caldas C, Reis-Filho JS, Aparicio SA, Salomon AV, Børresen-Dale AL, Richardson AL, Campbell PJ, Futreal PA, Stratton MR.

Nature. 2012 May 16;486(7403):400-4. doi: 10.1038/nature11017.

PMID:
22722201
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Gene modules and response to neoadjuvant chemotherapy in breast cancer subtypes: a pooled analysis.

Ignatiadis M, Singhal SK, Desmedt C, Haibe-Kains B, Criscitiello C, Andre F, Loi S, Piccart M, Michiels S, Sotiriou C.

J Clin Oncol. 2012 Jun 1;30(16):1996-2004. doi: 10.1200/JCO.2011.39.5624. Epub 2012 Apr 16.

PMID:
22508827
[PubMed - indexed for MEDLINE]
18.

A three-gene model to robustly identify breast cancer molecular subtypes.

Haibe-Kains B, Desmedt C, Loi S, Culhane AC, Bontempi G, Quackenbush J, Sotiriou C.

J Natl Cancer Inst. 2012 Feb 22;104(4):311-25. doi: 10.1093/jnci/djr545. Epub 2012 Jan 18.

PMID:
22262870
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Characterization and clinical evaluation of CD10+ stroma cells in the breast cancer microenvironment.

Desmedt C, Majjaj S, Kheddoumi N, Singhal SK, Haibe-Kains B, El Ouriaghli F, Chaboteaux C, Michiels S, Lallemand F, Journe F, Duvillier H, Loi S, Quackenbush J, Dekoninck S, Blanpain C, Lagneaux L, Houhou N, Delorenzi M, Larsimont D, Piccart M, Sotiriou C.

Clin Cancer Res. 2012 Feb 15;18(4):1004-14. doi: 10.1158/1078-0432.CCR-11-0383. Epub 2012 Jan 10.

PMID:
22235100
[PubMed - indexed for MEDLINE]
Free Article
20.

Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions.

Pradeep CR, Zeisel A, Köstler WJ, Lauriola M, Jacob-Hirsch J, Haibe-Kains B, Amariglio N, Ben-Chetrit N, Emde A, Solomonov I, Neufeld G, Piccart M, Sagi I, Sotiriou C, Rechavi G, Domany E, Desmedt C, Yarden Y.

Oncogene. 2012 Aug 2;31(31):3569-83. doi: 10.1038/onc.2011.547. Epub 2011 Dec 5.

PMID:
22139081
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk